Abstract

BackgroundThe survival of INA-6 human multiple myeloma cells is strictly dependent upon the Interleukin-6-activated transcription factor STAT3. Although transcriptional analyses have revealed many genes regulated by STAT3, to date no protein-coding STAT3 target gene is known to mediate survival in INA-6 cells. Therefore, the aim here was to identify and analyze non-protein-coding STAT3 target genes. In addition to the oncogenic microRNA-21, we previously described five long noncoding RNAs (lncRNAs) induced by STAT3, named STAiRs. Here, we focus on STAT3-induced RNA 18 (STAiR18), an mRNA-like, long ncRNA that is duplicated in the human lineage. One STAiR18 locus is annotated as the already well described LINC00152/CYTOR, however, the other harbors the MIR4435-2HG gene and is, up to now, barely described.MethodsCAPTURE-RNA-sequencing was used to analyze STAiR18 transcript architecture. To identify the STAiR18 and STAT3 phenotype, siRNA-based knockdowns were performed and microarrays were applied to identify their target genes. RNA-binding partners of STAiR18 were determined by Chromatin-Isolation-by-RNA-Purification (ChIRP) and subsequent sequencing. STAT3 expression in dependence of STAiR18 was investigated by immunoblots, chromatin- and RNA-immunoprecipitations.ResultsAs identified by CAPTURE-RNA sequencing, a complex splice pattern originates from both STAiR18 loci, generating different transcripts. Knockdown of the most abundant STAiR18 isoforms dramatically decreased INA-6 cell vitality, suggesting a functional role in myeloma cells. Additionally, STAiR18 and STAT3 knockdowns yielded overlapping changes of transcription patterns in INA-6 cells, suggesting a close functional interplay between the two factors. Moreover, Chromatin isolation by RNA purification (ChIRP), followed by genome-wide RNA sequencing showed that STAiR18 associates specifically with the STAT3 primary transcript. Furthermore, the knockdown of STAiR18 reduced STAT3 levels on both the RNA and protein levels, suggesting a positive feedback between both molecules. Furthermore, STAiR18 knockdown changes the histone methylation status of the STAT3 locus, which explains the positive feedback and indicates that STAiR18 is an epigenetic modulator.ConclusionHence, STAiR18 is an important regulator of myeloma cell survival and is strongly associated with the oncogenic function of STAT3. The close functional interplay between STAT3 and STAiR18 suggests a novel principle of regulatory interactions between long ncRNAs and signaling pathways.

Highlights

  • The survival of Multiple myeloma cell line (INA-6) human multiple myeloma cells is strictly dependent upon the Interleukin-6activated transcription factor Signal Transducer and Activator of Transcription 3 (STAT3)

  • STAT3-induced RNA 18 (STAiR18) is an important regulator of myeloma cell survival and is strongly associated with the oncogenic function of STAT3

  • The close functional interplay between STAT3 and STAiR18 suggests a novel principle of regulatory interactions between long Noncoding RNA (ncRNA) and signaling pathways

Read more

Summary

Introduction

The survival of INA-6 human multiple myeloma cells is strictly dependent upon the Interleukin-6activated transcription factor STAT3. In a previous publication [8], we characterized five of these IL-6-induced lncRNAs (STAiR1, STAiR2, STAiR6, STAiR15 and STAiR18) in more detail, verifying them as STAT3 targets, and named them STAT3induced ncRNAs (STAiRs) Out of this pool of STAiRs, we focused on STAiR18 for the following reasons: In contrast to the unprocessed macroRNAs STAiR1, − 2 and − 6, STAiR15 and − 18 were spliced and suited better to carry out functional analyses by siRNAbased knockdown strategies. Our preliminary data supported the view that STAiR18 contributes to STAT3-dependent tumorigenesis in multiple myeloma as well as in other cancer entities [8] This observation has since been confirmed by further publications [11,12,13]. The goal was to elucidate the role of STAiR18 within the STAT3 signaling cascade

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call